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Coherence between self-reported and objectively 
measured physical activity in patients with chronic 
obstructive lung disease: a systematic review
Mimi Thyregod1,2
Uffe Bodtger1,2
1Department of Respiratory Medicine, 
Naestved Hospital, Naestved, 
2Institute for Regional Health 
Research, University of Southern 
Denmark, Odense, Denmark
Abstract: The beneficial effects of physical activity (PA) in patients with COPD, as well as the 
methods of their assessment, are well known and described. As objective measures of PA, such 
as the use of motion sensors, video recordings, exercise capacity testing, and indirect calorimetry, 
are not easily obtained in the daily clinical life, the reliability of the more accessible self-reported 
measurements of PA is important. In this review, we systematically identified original studies 
involving COPD patients and at least one parameter of self-reported and objective exercise 
testing, and analyzed every article for coherence between the objectively and self-reported 
measured PA. The studies are few, small, and very diverse, both in their use of questionnaires 
and objective measurements. Self-reported assessments were found to generally overestimate 
the level of PA compared to measurements made objectively by activity monitors; however, 
more studies are needed to rely solely on the use of PA questionnaires in COPD patients. The 
most accurate and valid questionnaires appear to be the self-completed Physical Activity Scale 
for the Elderly and the interviewer-completed Stanford Seven-Day Physical Activity Recall 
Questionnaire, but the ideal questionnaire still awaits construction. The motion sensors are 
accurate and validated in this patient group, especially SenseWear™, but not easily accessible 
in clinical practice, as they have various technical and adhesive difficulties.
Keywords: respiratory medicine, COPD, physical activity monitoring, questionnaire, motion 
sensor
Introduction
The level of PA in patients with COPD is inversely correlated with disease severity: 
lung function decline, disease burden, frequency of hospitalization, and mortality.1,2 PA 
is defined as any bodily movement produced by skeletal muscles that results in energy 
expenditure.3 In COPD patients, the amount of PA is reduced compared to matched 
controls, as a result of – among other things – decreased threshold for exercise-induced 
dyspnea due to the irreversible airflow obstruction.4 PA is efficacious in alleviating the 
vicious circle of deconditioning, and is the cornerstone of pulmonary rehabilitation.5,6
In COPD, correct assessment of PA in daily life is crucial to allocate patients to 
correct interventions: self-training, tele-health-based training, community-based or 
hospital-based pulmonary rehabilitation. In addition, knowledge of PA levels can moti-
vate patients to improve, thereby reducing the morbidity and mortality by maintaining 
a proper PA level.7–9 Unfortunately, the correct assessment of a patient’s PA levels is 
difficult, and no GOLD standard exists to quantify the amount of PA.10
PA levels can be assessed objectively or subjectively (self-reported), prospectively 
or retrospectively, and in experimental or real-life settings. Exercise capacity tests 
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(objective/prospective/experimental setting), eg, the six-
minute walk test (6MWT) or the incremental shuttle walk test 
(ISWT), are routinely used in rehabilitation programs and then 
a patient’s daily PA levels are extrapolated from these tests, 
although a recent study showed a moderate-to-weak correla-
tion to PA levels when the number of steps were measured 
by a pedometer.11 Other objective assessments often used in 
research settings or in athletes are the measurements of VO
2
 
max and energy expenditure with indirect calorimetry (DLW 
method), which are considered as golden standard methods.12 
Yet, assessment of PA energy expenditure does not quantify the 
duration, frequency, and intensity of the PA performed. Video 
recordings or activity monitors are examples of objective, 
prospective assessments in real-life settings (see “Objective 
methods for quantification of daily PA” section below), and the 
importance of the latter has recently been elaborately reviewed 
by Liao et al.13 Self-reported PA is more easily accessible 
and cheaper in both clinical life and epidemiological studies 
compared to video recordings or activity monitors – although 
often not very reliable. The most commonly used methods 
are self-reported, retrospective questionnaires on PA, whereas 
daily entries in a PA diary are less often used. Few question-
naires have been validated in COPD populations, which are 
characterized by much lower levels of PA compared to the 
general population (see “Objective methods for quantification 
of daily PA” section below).
Therefore, we aimed at performing a systematic review to 
investigate the agreement between self-reported and objec-
tively measured PA in daily life, as well as the reliability and 
validity of each method and most importantly, the clinical 
application thereof. The following two sections describe the 
different methods followed for both subjective/self-reported 
and objective assessments.
Objective methods for quantification of  
daily PA
The Tuscan Renaissance artist and inventor Leonardo da Vinci 
drew the first sketches of a motion sensor in the 15th century: 
a pedometer held by both hands and looking like a wheelbar-
row.14 Today, motion sensors are body-worn and divided into 
three categories: accelerometer (uniaxial, biaxial, triaxial), 
multisensor device, and pedometer. Accelerometers detect 
activity through changes in velocity as well as frequency, 
intensity, and duration of the activity. Their cost and techni-
cal complexity are higher than regular pedometers that only 
collect steps by vertical accelerations. The multisensor device 
combines the triaxial accelerometer with sensors (heat flux, 
galvanic skin response and skin temperature). Within each 
category, motion sensors differ in economic costs, technical 
complexity, and placement on the body (hip, arm, ankle, etc.). 
This is often a practical challenge in patients using walking 
aids, such as a walking stick or a walker, in addition to the 
use of motion systems in different environments such as in 
the water to record swimming or bicyling as examples.15
Questionnaires for quantification of  
daily PA
Self-reported measurements include diaries, logbooks, 
and questionnaires. Overall, questionnaires are classified 
into three categories: global, recall, and quantitative.16 The 
global questionnaire is short, self-administered, and usually 
consists of 2–4 questions, and can be used to assess whether 
a patient fulfills the international daily PA requirement 
of 30 minutes. The short recall questionnaire commonly 
includes 7–12 items and can be either interviewer- or self-
administered. The quantitative questionnaire is longer, typi-
cally includes 20–60 questions and provides in greater detail 
the PA level over a longer period of time.
The following validated questionnaires were used in the 
papers included in the study: PASE, PAR, Baecke Physical 
Activity Questionnaire, ZPAQ, and MARQ.17–19 Other 
validated questionnaires for the COPD population include 
Yale Physical Activity Survey20 and Minnesota Leisure 
Time Physical Activity Questionnaire, among others.20,21 
A summary of the questionnaires featured in this review is 
presented in Table 1. The questionnaires are divided into four 
categories: multi- or single-item questionnaire, and validated 
or nonvalidated questionnaire in COPD populations.
Methods
A literature search was performed using PubMed on March 5, 
2016, using the terms “Physical activity”, “Monitoring” 
or “Measuring”, “COPD”, “Self-reported”, “objective”, 
and “correlation” or “coherence”. We had no limitations 
concerning the publication year. Inclusion criteria were the 
following: 1) studies including patients with known COPD, 
2) original studies involving PA, 3) objective measurement 
of the level of daily PA, 4) self-reported measurement of 
the level of daily PA, 5) peer-reviewed papers published in 
English. Exclusion criteria were the following: 1) studies 
including patients with diagnoses other than COPD, and 
without clear data separation between COPD and non-COPD 
groups and 2) studies reporting only subjective or objective 
PA measurement.
All identified abstracts were independently screened by 
two persons (MT and UB) and discussed with an experienced 
pulmonologist in COPD (Dr Anders Løkke) in case of 
disagreement.
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Table 1 Overview of the questionnaires
Study Questionnaire Administration 
form
No of questions Recall 
time
Classification of  
physical activity
Outcome
18 PAR Interviewer 4 including complete 
minute to minute diary
7 days Moderate, hard, very hard Minutes 
18 Baecke Self 16 12 months Light, moderate, hard Minutes
18 Zutphen Self 17 1 month Moderate, hard, very hard Minutes
17,18 PASe Self 32 7 days Light, moderate, strenuous,  
recreation
Hours -. score
17 SBAS Self 2 1 day Inactive, light, moderate, hard, 
very hard
Score
19 MARQ Self – – All activities energy expenditure
23 SQUASH Self 13 7 days Light, moderate, intense Intensity scores based  
on the reported effort
Abbreviations: MARQ, Modified Activity Recall Questionnaire; PAR, the Stanford Seven-Day Physical Activity Recall Questionnaire; PASE, Physical Activity Scale for the 
Elderly; SBAS, Stanford Brief Activity Scale; SQUASH, Short Questionnaire to Assess Health-enhancing physical activity.
Important definitions
SPI: the PAL is obtained by dividing the total daily energy 
expenditure by the resting energy expenditure, measured by 
an activity monitor. SPI is defined as PAL ,1.40.17
MET: a physiological measure expressing the energy cost 
of PA, as measured by an activity monitor. MET score is 
defined as follows: ,3 light activities, 3–6 moderate activi-
ties, and .6 vigorous activities.18
Outcome
Primary outcome: difference in PA. Self-reported PA as a 
fraction of measured PA, possibly reported in the original 
study as Pearson’s correlation.
Secondary outcomes: Percentage of SPI by questionnaire 
compared to objective measurements.
Results
The search process resulted in identification of 39 abstracts, 
and after review, 7 original papers (Figure 1) were selected 
for the study. During the review process, most studies were 
discarded due to a lack of either an objective or a subjective 
measure of self-reported PA (n=30). A few studies were 
published in non-English languages (n=2). Table 2 depicts 
differences in sample size, PA and methods for objective 
and subjective measurements of PA in the various studies. 
All included papers involved motion sensors. The study 
could not find any relevant RCTs on the subject, only 
cohort studies.
Risk of bias
According to the NOS, we assessed the quality of the 
included studies, as given in Table 3.22 Agreement between 
the reviewers (MT and UB) was calculated and expressed 
as a percentage and quantified by kappa statistics; the results 
revealed an agreement of 81% and a kappa value of 0.74.
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Figure 1 Flow diagram of search results.
validated multi-item questionnaire
In an English study, PAR was compared with a SenseWear™ 
(Bodymedia, Pittsburgh, PA, USA) multisensor and validated 
using three other validated PA questionnaires: Baecke, 
PASE, and ZPAQ (Table 2).13,18
The study included 43 COPD patients who wore 
SenseWear™ for 7 days. A significant correlation between 
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the TEE derived by PAR and SenseWear™ was observed 
in patients with moderate PA (MET $3, r=0.83). Further-
more, PAR correctly predicted patients at each end of the PA 
scale as very inactive and very active patients. In addition, the 
patients completed a 6MWT that did not predict the active 
patients, according to the PA detected by SenseWear™.
Likewise, DePew et al applied both the PASE question-
naire and SenseWear™.17 PASE demonstrated a moderate 
correlation with the PAL measured by SenseWear™ in 67 
COPD patients with a positive correlation coefficient (r=0.62). 
Using a cut-off PASE score of ,111, it predicted SPI mea-
sured by SenseWear™, with a negative predictive value of 
0.65 and a positive predictive value of 0.83, indicating an 
underestimation of SPI utilizing a PASE questionnaire.
The best predictor of SPI was the mMRC $3, although 
PASE and mMRC together achieved an even better correla-
tion (concordance correlation coefficient 0.833).
Another study compared the MARQ, a self-reported PA 
questionnaire which assesses energy expenditure, with the 
TriTrac-R3D accelerometer in 47 COPD patients.19
No significant relationship was found between reported 
and measured PA, and the low correlation (r=0.4) suggests 
profound overestimation of PA measured by the MARQ. 
In the same study, PA observed during 6MWT correlated 
significantly with that measured by TriTrac-R3D (r=0.74).
Nonvalidated multi-item questionnaire
A Dutch study investigated PA in 47 lung-transplant candi-
dates and 15 lung-transplant recipients. Measurement with 
a pedometer (with a wearing time of 10 days, where the last 
7 days were included in the measurements) was compared to 
the SQUASH.23 The correlation coefficient was not calculated 
between the pedometer and the SQUASH. The SQUASH 
divides the activities in MET scores. In the study, the total 
amount of activity was calculated and defined as “steps 
equivalent”, using the data from the pedometer (steps) and the 
SQUASH, converting PA where steps could not be counted, 
eg, cycling and swimming. The calculated steps equivalent 
per day was almost twice as high in the lung-transplant can-
didate group when compared with the steps measured by the 
pedometer (1,407±1,166 vs 2,636±2,275 steps equivalent). 
In the lung-transplant recipient group, the calculated steps 
equivalent was almost one-third higher than the pedom-
eter-measured steps (6,642±2,886 vs 9,038±4,583 steps 
equivalent). Even though the correlation coefficient was not 
calculated, the study showed a relative overestimation of the 
self-reported PA compared to the measured PA.
Nonvalidated single-item score
A similar study was carried out by Moore et al in 76 COPD 
patients using a pedometer and a simple 7-day PA diary.24 
A significant, but poor or moderate correlation (r=0.37) 
was demonstrated using a modified diary developed by 
Follick et al.25 It consisted of four categories of activi-
ties (sleeping, sitting, standing/walking, lying) and was 
completed a minimum of three times per day. The authors 
concluded that the pedometer used underestimated PA lev-
els, and that the diary was a more accurate measure of PA, 
yet no other objective measure was established to confirm 
this assertion. A small study with 11 COPD patients and 
9 healthy age-matched controls investigated if brisk walking 
was detected by an accelerometer worn for 48 hours.26 The 
COPD patients had recently completed pulmonary rehabilita-
tion, and brisk walking was defined as 60% of the predicted 
peak oxygen consumption in ISWT. No data on how brisk 
walking was defined in the healthy age-matched controls 
were provided. The COPD patients recorded daily PA in 10 
different categories: lying, sitting, sitting activity, standing, 
standing activity, personal, walking (brisk), walking (slow/
intermittent), driving, and others. There was a significant 
correlation between the diary recorded brisk walking and 
that counted by the accelerometer, but there was a wide 
range in the standard deviation scores in all other categories. 
No results on whether the diary over- or underestimated PA 
according to the accelerometer were provided in the paper, 
but step count differed insignificantly between lying and all 
activities, except for brisk walking – suggesting overestima-
tion of self-reported PA.
Pitta et al performed two unrelated studies: A and B.27 In 
study A, a small group of 10 patients with COPD correlated 
Table 3 Risk of bias
The Newcastle–Ottawa Scale (NOS) for assessing the quality 
of nonrandomized studies
Study Risk of bias assessment
Selection 
(0–3)
Comparability 
(0–2)
Outcome 
(0–3)
Total 
score
Garfield et al18 2 – 3 5
DePew et al17 2 – 3 5
Steele et al19 2 – 3 5
Bossenbroek et al23 1 – 3 4
Moore et al24 0 – 3 3
Singh and Morgan26 2 1 2 5
Pitta et al27 2 – 3 5
Mean 1.6 1 2.9 32
Notes: Domain 1 (selection) scored out of 3, and not out of 4, as the “outcome 
of interest was not present at start of the study”, was considered not appropriate 
for this review.
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patient estimations, DAM, and video recordings in a 1-hour 
standardized protocol, whereas study B, consisting of 13 
other COPD patients, correlated DAM, and a self-report in a 
regular-day protocol. The self-report consisted of a logbook, 
reporting on an hourly basis the time spent on each activity 
or body position. In study A, patients significantly underesti-
mated sitting time in the self-report. DAM and video record-
ings were correlated, even though the DAM systematically 
slightly overestimated walking and cycling time. There was 
a high disagreement between the self-report and the video 
recordings. In study B, patients significantly overestimated 
walking time (r=0.71) and underestimated standing time in 
the self-report compared to the DAM.
Discussion
The review unveils the existence of few and heterogeneous 
studies using accelerometers and self-reported PA simultane-
ously, resulting in a low validity and test–retest reliability. 
Heterogeneity was observed in patient selection (ranging 
from mild to very severe COPD), intensity, and duration 
of PA. Steele et al confirmed the correlation between FEV
1
 
and PA, as measured by the accelerometer and the 6MWT, 
highlighting the relationship between airway obstruction and 
maximum exercise capacity.19,23,28 A general overestimation 
of self-reported PA was demonstrated, and no reliable PA 
questionnaire was found.17,19,27,29 The most accurate tool for 
self-reported PA based on the papers assessed here is to keep 
a daily diary with a description of all activities.24
However, two questionnaires predicted very low levels 
of daily PA: PASE and PAR. The PASE questionnaire was 
able to predict SPI in COPD patients, although, together with 
mMRC, it had a more accurate outcome.17 The PAR question-
naire was the only questionnaire to reach significant correlation 
with SenseWear™.18 However, this finding was only observed 
in the subgroup of COPD patients reaching a moderate PA 
level (MET $3). The authors concluded that PAR predicted 
PA only as a binary outcome (active/inactive) with respect to 
PA levels. Since PAR was an interviewer-led questionnaire, 
it was difficult to use this in an epidemiological setting.
Various challenges are associated with PA recollection 
in COPD patients. An accurate PA questionnaire in the, 
mostly sedentary, COPD population should include various 
questions on the reasons for low PA. The PASE questionnaire 
was designed for an elderly population, whereas the valida-
tion of the SQUASH questionnaire was done in a subgroup 
including mostly men (70%), with a mean age of 44 years, 
and 50% had a good or high fitness level, which is far from 
that expected for the COPD population.17,30
Questionnaires are either interviewer administered or 
self-completed by the patient. Of the questionnaires included 
in this review, only PAR was interviewer administered, with 
the risk of over-administration the answers. On the other 
hand, there might be a risk of missing data when using self-
administered questionnaires, as well as misunderstanding of 
both content- and time-related questions.
Cognitive impairment in COPD has gained increasing 
attention.31 Recollecting the details of daily life activities, 
including PA, is evidently hampered in the most diseased 
COPD patients, and therefore reliability of the data collected 
has been questioned.27,32,33 The health benefits of normal PA 
are widely accepted.5,6,13 These influence the patients’ self-
reporting measurements, resulting in a tendency to overesti-
mate PA levels, which is found in this review as well.17,19,27,29,33 
Recall bias is also affected by time factors, such as when and 
how the questionnaire is to be completed, and the amount 
of time the patient has to recall. The Baecke questionnaire 
covers the preceding year, and previously we have shown that 
otherwise healthy patients with seasonal pollen allergy only 
recollected the single day with the most symptoms 4 months 
after the pollen season. Thus, recollection of PA during an 
entire year is unlikely to be reliable or correct.17,34
A significant dropout rate is also a well-known problem in 
the COPD population, making it even harder to generalize the 
results to the entire COPD population as only the healthiest 
patients complete each study.28
Accelerometers have very different ways of calculating 
and reporting energy expenditure and PA, and it is mandatory 
to convert the reported output for comparison with that of 
questionnaire-based self-reported PA, work capacity testing, 
or other activity monitors. A device’s test–retest reliability 
and validity is typically derived in a non-COPD population. 
Measuring PA in the relatively inactive COPD population 
results in a rather narrow PA range as most time is spent 
sedentary with a low PA level concerning both duration 
and intensity.12 This results in a demand for highly sensitive 
activity monitors that can detect differences in PA even in 
very inactive patients, including a measurement of PA that 
does not involve total body movement, such as weight lifting 
and stationary cycling.19,29
In addition to the challenge of recollecting PA, Pitta et al 
reported adherence difficulties upon using an accelerometer 
in 19% of COPD subjects including body placement and tech-
nical issues, such as battery problems.29 Additionally, Moore 
et al demonstrated that 18% of COPD patients failed to use a 
simple pedometer correctly; furthermore, 5% completed the 
diary insufficiently.24 These failure rates are probably higher 
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Coherence between self-reported and objectively measured PA in COPD
in unselected, everyday patients who do not feel obliged to 
please an investigator during a clinical trial.
The limitations of this study are the lack of high-quality, 
high-volume studies and not all the included studies published 
coherence between self-reported and objectively measured 
PA. Only two studies included .50 patients.17,24 This review 
unveils a critical need for a more accurate PA questionnaire 
in the COPD population, as objective measures are costly, 
time-consuming and prone to adherence difficulties as well 
as patient-related issues.
Conclusion
The PA level has an impact on both prognosis of the patient and 
the disease severity. Assessment of daily PA is warranted to 
optimize PA-directed intervention. In the surprisingly few and 
small studies available on measurements of PA in daily life, 
self-reported assessments generally overestimated the level of 
PA measured objectively by activity monitors. However, the 
level of evidence is hampered by significant inter-study het-
erogeneity precluding statistical evaluation by meta-analysis. 
The most accurate and valid questionnaires appear to be the 
self-completed PASE and the interviewer-completed PAR 
questionnaires, but the ideal questionnaire still awaits con-
struction. Establishment of a well-defined golden standard of 
daily-life PA will improve the efforts in the development of a 
simple, accurate, and valid measurement of daily-life PA.
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